NASDAQ · Medical - Diagnostics & Research
ICON plc (ICLR) Stock
$164.17
-0.20%
NASDAQ: ICLR
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
ICON (ICLR) Stock May Be 33% Undervalued After Earnings Review Uncertainty
Simply Wall St. · Jul 9, 2026
ICON Public Limited Company (ICLR) Fell Due to Uncertainty Surrounding Reported Earnings
Insider Monkey · Jul 8, 2026
Truist Upgrades ICON to Buy From Hold, Raises Price Target to $207 From $159, Cites Stronger Bookings, Improving Margin Visibility
MT Newswires · Jun 30, 2026
Icon Reestablishes 'Credible' Path to Growth in 2027, RBC Capital Markets Says
MT Newswires · Jun 25, 2026
Company News for Jun 25, 2026
Zacks · Jun 25, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held0.44%
Institutions Held108.49%
Institutions Float Held108.97%
Peer Comparison
About ICON plc
ICON plc is led by CEO Barry Balfe, employs 40,100 people, headquartered in Dublin, IE, publicly traded since 1998.
ICON plc (ICLR) stock trades at $164.17 with a market capitalization of $12.57B. The stock is valued at a price-to-earnings (P/E) ratio of 37.77, price-to-book of 1.33, price-to-sales of 1.50. Over the past 52 weeks the stock has ranged between $66.57 and $203.91, and currently trades 19.5% below its 52-week high.
On profitability, ICON plc generates a return on equity (ROE) of 3.54%, return on capital employed of 6.72%, an operating margin of 13.26%, a net profit margin of 3.99%.